DO->IT

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation

DO->IT is the overall coordinator of the BD4BO activities within IMI and establishes the mechanisms for a sustainable focus on outcomes based healthcare delivery. DO->IT:

ensures quality, consistency and sustainability of health outcomes across BD4BO projects
integrates, synthesises, as well as is responsible for managing knowledge from BD4BO projects for easy access (knowledge exchange platform)
is a point of collaboration, stakeholder engagement and communication for BD4BO projects
additionally develops minimum data privacy standards for Informed Consent Forms (ICFs).

Partners:

London School of Economics and Political Science
Novartis
National Institute for Health and Care Excellence
Dental and Pharmaceutical Benefits Agency
European Cancer Patient Coalition
European Multiple Sclerosis Platform
Semmelweis University
Imperial College London
Swedi
sh Institute for Health Economics
Centre for Research in Healthcare Management– Università Bocconi
Norwegian Institute of Public Health
The Association of the British Pharmaceutical Industry
Amgen
Bayer
Boehringer Ingelheim
Celgene
European Federation of Pharmaceutical Industries and Associations
Farmaindustria
GlaxoSmithKline
Health iQ
InterSystems
Janssen Pharmaceutica NV
Eli Lilly and Company
Merck Group
MSD Sharp & Dohme
Novo Nordisk
Pfizer
Roche
Sanofi
Servier
UCB
Association of Research-Based Pharmaceutical Companies
Norwegian Medicines Agency
Technology, Methods and Infrastructure for Networked Medical Research
Inserm Toulouse

BD4BO
Big Data for Better Outcomes				Contact for BD4BO Website
This website has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (IMI2) under grant agreement No. 116055. This Joint Undertaking receives support from the European Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations (EFPIA).				Semmelweis University – Health Services Management Training Centre, Budapest Email: doit.communication@emk.sote.hu Legal notice

Definitions
Big Data	BD4BO
“Big data in health refers to largely routinely or automatically collected datasets, which are electronically captured and stored. It is reusable in the sense of multipurpose data and comprises the fusion and connection of existing databases for the purpose of improving health and health system performance.” (European Commission, Study on Big Data in Public Health, Telemedicine and Healthcare. 2016.)	Big Data for Better Outcomes is a comprehensive European research programme funded by the Innovative Medicines Initiative 2 Joint Undertaking (IMI2) aiming to develop key enablers to support healthcare system transformation through the use of big data.
DO->IT	Core outcome sets
“Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation” is the Coordination and Support Action project of the BD4BO programme.	the agreed minimum standardised set of outcomes that should be measured and reported in trials or other research on a specific condition.

Leave a Reply Cancel reply